Previously, P&G maintained its guidance range for fiscal 2025 all-in sales growth to be in the range of 2%-4% versus the prior year, stating that the combined headwinds from foreign exchange and divestitures are expected to negatively impact all-in sales growth by approximately one percentage point. The company also maintained its outlook for organic sales growth in the range of 3%-5%. During its investor day presentation, the company says it could be at the lower end of its view if China and the Middle East continue to decelerate.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Eli Lilly appoints Jon Moeller to board of directors
- Insider Trading: Procter & Gamble’s (PG) Key Executive Sells Stock Worth $2.2M
- Procter & Gamble price target raised to $180 from $175 at Truist
- Procter & Gamble price target raised to $191 from $174 at Morgan Stanley
- Procter & Gamble price target raised to $183 from $180 at Evercore ISI